Skip to content
797797797

Drawing based on the label description. No photo yet.

“The 250 mg tablets are orange colored, oval shaped, biconvex coated tablets imprinted '797' with black ink on one side and plain on the other side”

797 pill

Pill with imprint 797 is orange, oval, 15 mm and has been identified as Divalproex Sodium D/R 250 mg. It is used for bipolar disorder. It is supplied by Direct_rx.

Divalproex Sodium D/R 250 mg

Imprint
797
Strength
250 mg
Used for
Bipolar disorder
Color
Orange
Shape
Oval
Size
15 mm
Score
No score line
Form
Tablet, delayed release
Manufacturer
Direct_rx
NDC
72189-636, 62756-797, 72189-636-60

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Divalproex Sodium D/R pills and guides

What is Divalproex Sodium D/R used for?

Divalproex Sodium D/R is used for bipolar disorder.

Official uses from the US prescribing label

1.1 Mania

Divalproex sodium is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder. A manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. Typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. The efficacy of divalproex sodium delayed-release tablets was established in 3-week trials with patients meeting DSM-III-R criteria for bipolar disorder who were hospitalized for acute mania.

The safety and effectiveness of divalproex sodium delayed-release tablets for long-term use in mania, i.e., more than 3 weeks, has not been demonstrated in controlled clinical trials. Therefore, healthcare providers who elect to use divalproex sodium delayed-release tablets for extended periods should continually reevaluate the long-term usefulness of the drug for the individual patient.

1.2 Epilepsy

Divalproex sodium delayed-release tablets are indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Divalproex sodium delayed-release tablets are also indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present.

1.3 Migraine

Divalproex sodium delayed-release tablets are indicated for prophylaxis of migraine headaches. There is no evidence that divalproex sodium delayed-release tablets are useful in the acute treatment of migraine headaches.

1.4 Important Limitations

Because of the risk to the fetus of decreased IQ, neurodevelopmental disorders, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be used to treat women with epilepsy or bipolar disorder who are pregnant or who plan to become pregnant unless other medications have failed to provide adequate symptom control or are otherwise unacceptable. Valproate should not be administered to a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable.

For prophylaxis of migraine headaches, divalproex sodium is contraindicated in women who are pregnant and in women of childbearing potential who are not using effective contraception.

From the FDA-approved label on DailyMed (published Jul 30, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 797 and the other side is plain.
  • It is orange, oval, 15 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Divalproex Sodium

Inactive: Triacetin, Ammonia, Sodium Bicarbonate, Titanium Dioxide, Sodium Lauryl Sulfate, Fd&c Yellow No. 6, Ferric Oxide Yellow, Talc, Hypromellose, Unspecified, Triethyl Citrate, Propylene Glycol, Povidone, Unspecified, Shellac, Butyl Alcohol, Starch, Corn, Methacrylic Acid-Ethyl Acrylate Copolymer (1:1) Type A, Silicon Dioxide, Ferrosoferric Oxide

Other pills with imprint 797

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.